CN113896807A - Fresh rehmannia root polysaccharide and preparation method and application thereof - Google Patents
Fresh rehmannia root polysaccharide and preparation method and application thereof Download PDFInfo
- Publication number
- CN113896807A CN113896807A CN202111228586.3A CN202111228586A CN113896807A CN 113896807 A CN113896807 A CN 113896807A CN 202111228586 A CN202111228586 A CN 202111228586A CN 113896807 A CN113896807 A CN 113896807A
- Authority
- CN
- China
- Prior art keywords
- polysaccharide
- fresh rehmannia
- fresh
- rehmannia root
- column
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000004676 glycans Chemical class 0.000 title claims abstract description 96
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 94
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 94
- 241000405414 Rehmannia Species 0.000 title claims abstract description 74
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 241000405911 Rehmannia glutinosa Species 0.000 claims abstract description 26
- 150000002772 monosaccharides Chemical group 0.000 claims abstract description 11
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims abstract description 9
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims abstract description 9
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 8
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims abstract description 8
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims abstract description 8
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims abstract description 7
- 229930182830 galactose Natural products 0.000 claims abstract description 7
- 239000008103 glucose Substances 0.000 claims abstract description 7
- 238000000605 extraction Methods 0.000 claims abstract description 4
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims abstract description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 3
- 230000002519 immonomodulatory effect Effects 0.000 claims abstract description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 239000011780 sodium chloride Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 8
- 108090000790 Enzymes Proteins 0.000 claims description 8
- 229940088598 enzyme Drugs 0.000 claims description 8
- 238000001514 detection method Methods 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 5
- 229910001868 water Inorganic materials 0.000 claims description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- 238000004587 chromatography analysis Methods 0.000 claims description 4
- 238000005342 ion exchange Methods 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 229920002271 DEAE-Sepharose Polymers 0.000 claims description 3
- 108090000526 Papain Proteins 0.000 claims description 3
- 108010059820 Polygalacturonase Proteins 0.000 claims description 3
- 239000004365 Protease Substances 0.000 claims description 3
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 3
- 238000004255 ion exchange chromatography Methods 0.000 claims description 3
- 229940055729 papain Drugs 0.000 claims description 3
- 235000019834 papain Nutrition 0.000 claims description 3
- 229940124599 anti-inflammatory drug Drugs 0.000 claims description 2
- 238000013329 compounding Methods 0.000 claims description 2
- 230000002255 enzymatic effect Effects 0.000 claims description 2
- 239000000413 hydrolysate Substances 0.000 claims description 2
- 229940124622 immune-modulator drug Drugs 0.000 claims description 2
- 230000001376 precipitating effect Effects 0.000 claims description 2
- 238000001556 precipitation Methods 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 238000009210 therapy by ultrasound Methods 0.000 claims description 2
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 10
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 5
- 125000000089 arabinosyl group Chemical group C1([C@@H](O)[C@H](O)[C@H](O)CO1)* 0.000 abstract description 3
- 210000004027 cell Anatomy 0.000 description 20
- 239000000243 solution Substances 0.000 description 20
- 230000000694 effects Effects 0.000 description 19
- 210000002540 macrophage Anatomy 0.000 description 14
- 108010014251 Muramidase Proteins 0.000 description 12
- 102000016943 Muramidase Human genes 0.000 description 12
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 12
- 239000004325 lysozyme Substances 0.000 description 12
- 229960000274 lysozyme Drugs 0.000 description 12
- 235000010335 lysozyme Nutrition 0.000 description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 9
- 229910052799 carbon Inorganic materials 0.000 description 9
- 229910052739 hydrogen Inorganic materials 0.000 description 9
- 239000001257 hydrogen Substances 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 8
- 102000004127 Cytokines Human genes 0.000 description 7
- 108090000695 Cytokines Proteins 0.000 description 7
- 102000004889 Interleukin-6 Human genes 0.000 description 7
- 108090001005 Interleukin-6 Proteins 0.000 description 7
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 7
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 7
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 102000003777 Interleukin-1 beta Human genes 0.000 description 6
- 108090000193 Interleukin-1 beta Proteins 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 6
- 230000028327 secretion Effects 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 5
- 230000007365 immunoregulation Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 102100039855 Histone H1.2 Human genes 0.000 description 4
- 101001035375 Homo sapiens Histone H1.2 Proteins 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- 230000003698 anagen phase Effects 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 229940126680 traditional chinese medicines Drugs 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 206010057249 Phagocytosis Diseases 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 3
- 238000004192 high performance gel permeation chromatography Methods 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 238000007069 methylation reaction Methods 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 230000008782 phagocytosis Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 238000005100 correlation spectroscopy Methods 0.000 description 2
- 239000012531 culture fluid Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 238000000990 heteronuclear single quantum coherence spectrum Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N methylene chloride Substances ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 2
- 150000004804 polysaccharides Polymers 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- CBOJBBMQJBVCMW-BTVCFUMJSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;hydrochloride Chemical compound Cl.O=C[C@H](N)[C@@H](O)[C@H](O)[C@H](O)CO CBOJBBMQJBVCMW-BTVCFUMJSA-N 0.000 description 1
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 101500000959 Bacillus anthracis Protective antigen PA-20 Proteins 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- UGJBHEZMOKVTIM-UHFFFAOYSA-N N-formylglycine Chemical class OC(=O)CNC=O UGJBHEZMOKVTIM-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- OAABHEHWRQAHEJ-UHFFFAOYSA-N butan-1-ol;chloroform Chemical compound ClC(Cl)Cl.CCCCO OAABHEHWRQAHEJ-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000008004 cell lysis buffer Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960001911 glucosamine hydrochloride Drugs 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000003919 heteronuclear multiple bond coherence Methods 0.000 description 1
- 238000001052 heteronuclear multiple bond coherence spectrum Methods 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000003960 inflammatory cascade Effects 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Materials Engineering (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Sustainable Development (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种鲜地黄多糖及其制备方法和应用，属于天然药物和天然药物提取技术领域。所述鲜地黄多糖中的单糖单元包括鼠李糖、阿拉伯糖、半乳糖、葡萄糖，其分子量为17.1KDa。其中鼠李糖：阿拉伯糖：半乳糖：葡萄糖的摩尔比为25.1：26.2：28.7：20.0。所述鲜地黄多糖的主链为→3,6)‑β‑D‑Galp‑(1→6)‑β‑D‑Galp‑(1→，支链为→5)‑α‑L‑Araf‑(1→2,5)‑α‑L‑Araf‑(1→的阿拉伯糖链，并通过→3,6)‑β‑D‑Galp‑(1→的O‑3连接在主链上。本发明公开的鲜地黄多糖，具有免疫调节和抗炎活性。
The invention discloses a fresh rehmannia polysaccharide and a preparation method and application thereof, belonging to the technical field of natural medicine and natural medicine extraction. The monosaccharide unit in the fresh rehmannia polysaccharide includes rhamnose, arabinose, galactose, and glucose, and its molecular weight is 17.1KDa. The molar ratio of rhamnose:arabinose:galactose:glucose is 25.1:26.2:28.7:20.0. The main chain of the Rehmannia glutinosa polysaccharide is →3,6)-β-D-Galp-(1→6)-β-D-Galp-(1→, and the branched chain is →5)-α-L-Araf- The arabinose chain of (1→2,5)-α-L-Araf-(1→ is connected to the main chain through the O-3 of →3,6)-β-D-Galp-(1→. This The fresh rehmannia polysaccharide disclosed by the invention has immunomodulatory and anti-inflammatory activities.
Description
Technical Field
The invention relates to the technical field of natural medicines and natural medicine extraction, in particular to a fresh rehmannia root polysaccharide and a preparation method and application thereof.
Background
The polysaccharide is a chemical component commonly existing in traditional Chinese medicines, almost all plant traditional Chinese medicines contain the component, and the polysaccharide is an important material basis for the traditional Chinese medicines to play the drug effect and has the effects of reducing blood fat, reducing blood sugar, resisting tumors, enhancing the immune function and the like. In recent years, with the further development of scientific research, the unique pharmacological activity of polysaccharide components is gradually recognized, and the traditional Chinese medicine polysaccharide has become the focus of common attention of modern medicine and food functional chemistry. Many researches show that the traditional Chinese medicine polysaccharide generally has a good effect on immune function, and the change of the immune function and inflammatory reaction are accompanied in the occurrence of most diseases. Macrophages, which are important effector cells of the immune system, are considered as target cells of various immunomodulatory and anti-inflammatory drugs, and have the effects of secreting various cytokines, activating immune response, participating in inflammatory cascade, and the like. In the treatment of diseases, traditional Chinese medicines often play an anti-inflammatory role by regulating the immune process of an organism and reduce the injury of the organism, thereby intervening the occurrence and development of diseases.
The rehmanniae radix is fresh root tuber or dried root tuber of Rehmannia glutinosa Libosch of Scrophulariaceae family. Fresh, or slowly bake rehmannia glutinosa until about eighty percent dry. Since Shen nong Ben Cao Jing (Shen nong's herbal), its clinical application history is long, it is mainly divided into fresh rehmannia root, Sheng Di Huang and Shu Di Huang, all having the effect of tonifying, and the fresh herb is called fresh rehmannia root. Fresh rehmannia root, sweet in taste, bitter and cold in nature, enters heart, liver and kidney channels, and has the effects of clearing heat, promoting fluid, cooling blood and stopping bleeding; can be used for treating yin impairment due to febrile disease, crimson tongue with dipsosis, toxic heat, macula, hematemesis, epistaxis, and sore throat. The actions of Xian Di Huang for clearing heat and cooling blood, such as treating high fever acute syndrome and recklessly blood flow due to blood heat, are superior to those of dry product, and they cannot be used together. The fresh rehmannia root has a long history of administration, and the ancient herbal medical records the use characteristics of pounding (grinding) rehmannia root juice for drinking or coating. Modern researches show that rehmannia contains abundant polysaccharide components, and is an important active component of rehmannia for playing the drug effect. The rehmanniae radix polysaccharide has biological activities of improving immunity, resisting tumor, relieving fatigue, and resisting anxiety. The fresh rehmannia root juice is rich in polysaccharide components, but because the fresh rehmannia root is not easy to store, is sensitive to temperature and is easy to oxidize, the clinical application and activity research are less, and the immunoregulation effect of the fresh rehmannia root is not clear.
Disclosure of Invention
The invention aims to provide a fresh rehmannia root polysaccharide and a preparation method and application thereof.
In order to achieve the purpose, the invention provides the following technical scheme:
one of the technical schemes of the invention is as follows: providing a fresh rehmannia root polysaccharide, wherein monosaccharide units in the fresh rehmannia root polysaccharide comprise rhamnose (Rha), arabinose (Ara), galactose (Gal) and glucose (Glc); the molecular weight of the fresh rehmannia root polysaccharide is 17.1 KDa.
Preferably, the rhamnose: arabinose: galactose: the molar ratio of glucose was 25.1:26.2:28.7: 20.0.
Preferably, the main chain of the fresh rehmannia root polysaccharide is an arabinose chain which is → 3,6) -beta-D-Galp- (1 → 5) -alpha-L-Araf- (1 → 2,5) -alpha-L-Araf- (1 → and is connected to the main chain through → 3,6) -beta-D-Galp- (1 → O-3;
the bond → 6) -beta-D-Galp- (1 → the anomeric carbon of the polysaccharide of fresh rehmannia glutinosa is linked with → 6) -beta-D-Galp- (1 → H6; the glycosidic linkage → the anomeric carbon of 3,6) - β -D-Galp- (1 → is linked to H6 of → 6) - β -D-Galp- (1 →; the anomeric hydrogen of → 5) - α -L-Araf- (1 → is linked to C5 of → 2,5) - α -L-Araf- (1 →; the anomeric H1 of → 2,5) -alpha-L-Araf- (1 → is linked with C3 of → 3,6) -beta-D-Galp- (1 → is linked with the anomeric hydrogen of → 2,5) -alpha-L-Araf- (1 → C2 of → 2, 5).
The second technical scheme of the invention is as follows: provides a preparation method of the fresh rehmannia root polysaccharide, which comprises the following steps:
(1) carrying out enzymolysis on the fresh rehmannia by using compound enzyme, and precipitating enzymolysis liquid by using alcohol to obtain total polysaccharide of the fresh rehmannia;
(2) removing protein in the total polysaccharide of the fresh rehmannia root obtained in the step (1) by utilizing a Sevag method to obtain a crude polysaccharide solution of the fresh rehmannia root;
(3) separating the crude polysaccharide solution of the fresh rehmannia root obtained in the step (3) by an ion exchange chromatographic column; and performing gel column series chromatography to obtain fresh rehmanniae radix polysaccharide.
Preferably, the complex enzyme in the step (1) is obtained by compounding pectinase and papain in a mass ratio of 1: 1; the mass ratio of the compound enzyme to the fresh rehmannia is 0.15: 100; the volume ratio of the enzymolysis liquid to the fresh rehmannia is (5-10): 1.
Preferably, the specific operation of the enzymolysis in the step (1) is to add complex enzyme, adjust the pH value to 4-5, perform enzymolysis for 1h at 50 ℃, and perform ultrasonic treatment for 1h at 50 ℃ with the ultrasonic power of 80W.
Preferably, the alcohol precipitation in the step (1) is performed to adjust the alcohol concentration of the enzymatic hydrolysate to 90%.
Preferably, the extract used in the Sevag method in step (2) is a mixture of chloroform and n-butanol at a volume ratio of 4: 1.
More preferably, the number of times of extraction by the Sevag method is 3 to 5.
Preferably, the chromatographic conditions of the ion exchange chromatographic column separation in the step (3) are as follows:
a chromatographic column: DEAE-Sepharose FF column;
flow rate: 50 mL/h;
elution procedure: elution was sequentially carried out with water, 0.2M NaCl, 0.5M NaCl, 2M NaCl.
The invention utilizes phenol-sulfuric acid method to trace and detect the absorbance value of the eluent, and determines the elution time according to the detection result, the fresh rehmannia root polysaccharide selected by the invention is a sample contained in the eluent obtained by 0.2M NaCl elution.
Preferably, the gel column tandem chromatography conditions in step (3) are as follows:
a chromatographic column: gel Superdex-200;
detection conditions are as follows: LC-10A high performance liquid chromatograph, RI-502 differential detector;
mobile phase: 0.05M NaCl solution, flow rate: 0.6mL/min, column temperature: 40 ℃;
sample introduction amount: 20 μ L.
The third technical scheme of the invention is as follows: provides an application of the fresh rehmannia root polysaccharide in preparing an immunoregulation medicament or an anti-inflammatory medicament.
The invention has the following beneficial technical effects:
the invention provides a new fresh rehmannia root polysaccharide and a preparation method thereof. The preparation method provided by the invention is suitable for industrial production and provides a direction for quality control and standardized production of the fresh rehmannia root polysaccharide.
The method comprises the steps of extracting fresh rehmannia root polysaccharide by enzymolysis, combining ion exchange column chromatography and gel column chromatography, purifying and separating to obtain the fresh rehmannia root polysaccharide, determining the molecular weight by adopting high performance gel filtration chromatography (HPGPC), analyzing monosaccharide composition by an ion spectrometer, analyzing glycoside bond configuration and functional group information by an infrared spectrometer, analyzing the type of acetyl ester of sugar alcohol by GC-MS after methylation, judging monosaccharide residue, carrying out nuclear magnetic spectrum analysis on the monosaccharide residue, and determining the glycoside bond connection mode to obtain the new fresh rehmannia root polysaccharide.
The fresh rehmannia root polysaccharide provided by the invention has the immunoregulation and anti-inflammatory activities, and provides a direction for developing potential new medicines for immunoregulation and anti-inflammatory.
Drawings
FIG. 1 is a scattergram prepared by plotting the absorbance of an eluate eluted at a gradient in example 1.
FIG. 2 shows the results of the primary purified rehmannia glutinosa polysaccharide of example 1 passing through Sephadex Superdex-200 column and then detecting with a differential detector.
FIG. 3 is an HPGPC chart of fresh rehmannia glutinosa polysaccharide prepared in example 1.
FIG. 4 is an infrared spectrum of the polysaccharide of fresh rehmannia glutinosa prepared in example 1.
FIG. 5 is the HH-COSY spectrum of fresh rehmannia glutinosa polysaccharide prepared in example 1.
FIG. 6 is an HSQC spectrum of fresh rehmannia glutinosa polysaccharide prepared in example 1.
FIG. 7 is an HMBC profile of the fresh rehmannia glutinosa polysaccharide prepared in example 1.
FIG. 8 is a NOESY spectrum of the polysaccharides of fresh rehmannia glutinosa prepared in example 1.
Detailed Description
Reference will now be made in detail to various exemplary embodiments of the invention, the detailed description should not be construed as limiting the invention but as a more detailed description of certain aspects, features and embodiments of the invention. It is to be understood that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention.
Further, for numerical ranges in this disclosure, it is understood that each intervening value, between the upper and lower limit of that range, is also specifically disclosed. Every smaller range between any stated value or intervening value in a stated range and any other stated or intervening value in a stated range is encompassed within the invention. The upper and lower limits of these smaller ranges may independently be included or excluded in the range.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although only preferred methods and materials are described herein, any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention.
As used herein, the terms "comprising," "including," "having," "containing," and the like are open-ended terms that mean including, but not limited to.
The fresh rehmannia root used in the embodiment of the invention is selected from fresh radix rehmanniae tuberous roots of Huai-Dihuang, which is prepared from Henan Job's wort.
Example 1
Preparing fresh rehmannia root polysaccharide:
cutting 500g of fresh rehmannia root, adding 5 times of volume of distilled water, adding 75g of pectinase and papain (mass ratio of 1:1), adjusting the pH value to 4.5, uniformly stirring, carrying out enzymolysis at constant temperature of 50 ℃ for 1h, transferring the enzymolysis solution of the fresh rehmannia root into an ultrasonic extractor, carrying out ultrasonic extraction for 1h at 50 ℃ and power of 80W to obtain about 2.5L of extracting solution, filtering the extracting solution, concentrating by using a rotary thin-film evaporator to obtain fluid extract, dispersing and dissolving the fluid extract by using 100mL of distilled water, adding 95% industrial ethanol until the alcohol concentration reaches 90%, standing for 24h, centrifuging to obtain precipitate, and volatilizing the ethanol to obtain the total polysaccharide of the fresh rehmannia root.
Adding distilled water 5 times the volume of the obtained total polysaccharides of radix rehmanniae, adding 1/5 solution amount of chloroform-n-butanol (4:1) mixed solution according to Sevag method, extracting, shaking in shaking table for 20min, transferring to separating funnel, standing, collecting upper layer liquid, centrifuging for 1min to remove residual protein precipitate. Repeating the steps for 3 times to obtain crude polysaccharide solution of fresh rehmannia root after protein removal, and concentrating and drying under reduced pressure to obtain about 40g of crude polysaccharide of fresh rehmannia root.
Loading the obtained crude polysaccharide of rehmanniae radix on column (DEAE-Sepharose FF column), and connecting with flow collector and peristaltic pump. Sequentially eluting with distilled water, 0.2M NaCl, 0.5M NaCl and 2M NaCl, measuring absorbance at 490nm of the obtained eluates by phenol-sulfuric acid method, eluting each eluent until absorbance at 490nm is reduced to the minimum, replacing the next eluent, and drawing a scatter diagram (see FIG. 1) according to the measurement result. Collecting 0.2M NaCl eluate, concentrating, dialyzing with 3500Da dialysis bag, and freeze drying to obtain once-purified fresh rehmanniae radix polysaccharide, about 10.8 g.
Dissolving 100mg of once purified fresh rehmannia root polysaccharide in 3mL of distilled water, centrifuging by using a centrifuge (12000rpm) for 10min, further separating and purifying the supernatant by using a sephadex Superdex-200 column, and performing online detection by combining a differential detector under the detection conditions that: LC-10A high performance liquid chromatograph, RI-502 differential detector; mobile phase: 0.05M NaCl solution, flow rate: 0.6mL/min, column temperature: 40 ℃; sample introduction amount: 20 mu L, the detection result is shown in figure 2, the component of the third characteristic peak is collected (the component of the symmetrical peak is collected for 130-160 min in the experiment), the collected solution is concentrated by a rotary evaporator, and the fresh rehmannia root polysaccharide, about 15mg, is obtained by freeze drying.
Example 2
The fresh rehmannia root polysaccharide prepared in example 1 is subjected to structural verification:
(1) HPGPC measurement of molecular weight of fresh rehmannia glutinosa polysaccharide of example 1 (see FIG. 3)
Measuring with Shimadzu LC-10A high performance liquid chromatograph, RI-502 differential detector, and series gel chromatographic column (8 × 300 mm); mobile phase 0.05M NaCl solution, flow rate: 0.6mL/min, column temperature: 40 ℃; sample introduction amount: 20 μ L. Establishing a regression curve by using dextran standards with different molecular weights, and calculating the molecular weight. The dextran standard substance (molecular weight 1152, 5000, 11600, 23800, 48600, 80900, 148000, 273000) is prepared into 5mg/mL solution before mobile phase use, lg value of molecular weight is used as abscissa, retention time RT is used as ordinate to make standard curve, lgMp-RT correction curve equation is: Y-0.1933X +12.336 (R)20.9968); the lgMw-RT calibration curve equation is: -0.2064X +13.013, (R)20.9971); the lgMn-RT calibration curve equation is: -0.178X +13.033 (R)20.9969); the molecular weight of the fresh rehmannia root polysaccharide is calculated by a standard curve regression equation, and the measurement result is 17.1 KDa.
(2) Ion chromatography for measuring the content of each monosaccharide of the fresh rehmannia root polysaccharide in example 1
Separately, 4mg of polysaccharide was sampled, 1mL of 2M trifluoroacetic acid solution (TFA) was added, the mixture was sealed with nitrogen, and hydrolyzed at 120 ℃ for 3 hours. Precisely sucking 200 μ L of acid hydrolysis solution into a 1.5mL LEP tube, and blowing with nitrogen. 1mL of distilled water was added to the EP tube and dissolved by vortexing. The supernatant was centrifuged at 12000rpm for 5min and assayed by ion chromatography (ICS 5000). The chromatographic conditions are as follows: dionex CarbopacTM PA20 column (3X 150mm), column temperature 30 ℃, sample size 5. mu.L, flow rate: 0.3mL/min, mobile phase: a is H2O；B:250mM NaOHC:50mM NaOH&500mM NaOAC, detector: an electrochemical detector. The standard substance of mixed monosaccharide of rhamnose, arabinose, galactose, glucose, xylose, mannose, fructose, fucose, glucosamine hydrochloride, N-acetylglucosamine, glucuronic acid and galacturonic acid is used as a reference. The monosaccharide composition of the fresh rehmannia glutinosa polysaccharide was obtained and the results are shown in Table 1.
TABLE 1 monosaccharide composition of polysaccharides of fresh rehmannia glutinosa
(3) Methylation reaction to determine monosaccharide residues
Accurately weighing 3mg purified polysaccharide in a glass reaction bottle, adding 1mL anhydrous DMSO, rapidly adding NaOH powder, and adding N in a nitrogen blowing instrument2Blocking, dissolving with ultrasound, and adding 1mL iodomethane (CH)3I) The reaction was carried out for 60min in a magnetic stirring 30 ℃ water bath, and the methylation reaction was terminated by adding 2mL of ultrapure water. The methylated product was hydrolyzed by adding 2mol/L of LTFA1mL for 1.5h, and concentrated under reduced pressure on a rotary evaporator. After reduction of the hydrolysate, the residue was taken up in 2mL of double distilled water and washed with 60mg of sodium borohydride (NaBH)4) And reducing for 8 h. Then adding 0.1mL of glacial acetic acid for neutralization, concentrating by a rotary evaporator, drying by an oven at 101 ℃, then adding acetic anhydride, reacting at 1mL of 100 ℃ for 1h for acetylation, and cooling. 3mL of toluene was added, concentrated under reduced pressure to dryness, and repeated 5 times to remove excess acetic anhydride. The acetylated product was treated with 3mL of CH2Cl2Dissolve and extract 4 times with a distilled water separatory funnel. Removing the upper distilled water layer, CH2Cl2Drying with appropriate amount of anhydrous sodium sulfate, diluting to 10mL, filtering with 0.22 μm microporous membrane, and measuring and analyzing by GC-MS, the measurement results are shown in Table 2.
TABLE 2 GC-MS measurement results of methylated glycal acetyl ester of fresh rehmannia root polysaccharide
(3) Infrared spectrum of fresh rehmannia glutinosa polysaccharide prepared in example 1 (see FIG. 4)
As can be seen from FIG. 4, the absorption band of fresh rehmannia root polysaccharide is 3600--1Is a stretching vibration absorption peak of-OH, this regionThe absorption peak of (2) is a characteristic peak of the glucide. 3363cm-1Is the absorption peak of stretching vibration of O-H and is the characteristic peak of saccharide. At 2933cm-1There is an absorption peak, which is attributed to C-H stretching vibration. At 1650cm-1Absorption peak, attributed to stretching vibration of C ═ O. 1421cm-1Has an absorption peak which is attributed to C-O stretching vibration. At 1043cm-1Has an absorption peak belonging to O-H variable angle vibration.
(4) NMR spectra of the fresh rehmannia glutinosa polysaccharide prepared in example 1, wherein HH-COSY spectrum is shown in FIG. 5, HSQC spectrum is shown in FIG. 6, HMBC spectrum is shown in FIG. 7, and NOESY spectrum is shown in FIG. 8.
From FIG. 5, it can be observed that the anomeric carbon signal is δ 104.69, the corresponding anomeric hydrogen signal in FIG. 5 is δ 4.47, and from FIG. 6, it can be observed that the signal of H1-2 is 4.47/3.57; the signal of H2-3 is 3.57/3.68; signal 3.68/4.05 of H3-4; the signal of H4-5 is 4.05/3.87; the signal of H5-6a is 3.87/3.96; it can further be concluded that H1, H2, H3, H4, H5, and H6a are δ 4.47, 3.57, 3.68, 4.05, 3.87, and 3.96, respectively. Corresponding C1-C6 are 104.69, 71.31, 81.5, 69.82, 74.81, 70.76; therefore, the signal should be assigned to the glycosidic bond → 3,6) -Galp- (1 →.
From FIG. 5, it can be observed that the anomeric carbon signal is δ 108.81, the corresponding anomeric hydrogen signal in FIG. 5 is δ 5.12, and from FIG. 6, it can be observed that the signal for H1-2 is 5.12/4.04; the signal of H2-3 is 4.04/3.87; the signal of H3-4 is 3.87/4.01; the signal of H4-5a is 4.01/3.76; it can further be concluded that H1, H2, H3, H4, and H5a are δ 5.12, 4.04, 3.87, 4.01, and 3.76, respectively. The corresponding C1-C5 are 108.81, 82.62, 77.97, 85.22 and 62.64; therefore, the signal should be assigned to the glycosidic linkage α -L-Araf- (1 →.
From FIG. 5, it can be observed that the anomeric carbon signal is δ 108.8, and the corresponding anomeric hydrogen signal in FIG. 5 is δ 5.11, and from FIG. 6, it can be observed that the signal of H1-2 is 5.11/4.16; the signal of H2-3 is 4.16/4.09; signal 4.09/3.93 of H3-4; the signal of H4-5a is 3.93/3.80; it can further be concluded that H1, H2, H3, H4, and H5a are δ 5.11, 4.16, 4.09, 3.93, and 3.80, respectively. The corresponding C1-C5 is 108.8, 88.62, 77.1, 83.85, 67.81; therefore, the signal should be assigned to the glycosidic bond → 2,5) - α -L-Araf- (1 →.
From FIG. 5, an anomeric carbon signal of δ 108.8 can be observed, and the corresponding anomeric hydrogen signal in FIG. 5 is δ 5.01, and from FIG. 6, the signal of H1-2 is 5.01/4.05; the signal of H2-3 is 4.05/3.88; signal 3.88/4.16 of H3-4; the signal of H4-5a is 4.16/3.80; it can further be concluded that H1, H2, H3, H4, and H5a are δ 5.01, 4.05, 3.88, 4.16, and 3.80, respectively. The corresponding C1-C5 are 108.8, 82.52, 77.93, 83.6 and 67.81; thus, the signal should be assigned to the glycosidic bond → 5) - α -L-Araf- (1 →.
According to the nuclear magnetic one-dimensional two-dimensional maps in fig. 7 and 8, the glycosidic bond signals of the polysaccharides can be assigned;
the glycosidic bond → 6) - β -D-Galp- (1 → the anomeric carbon → 6) - β -D-Galp- (1 → H6 has a signal peak; indicating the presence of the → 6) - β -D-Galp- (1 → 6) - β -D-Galp- (1 → the linkage.
The anomeric hydrogen → 5) - α -L-Araf- (1 → has a correlation peak with C5 → 2,5) - α -L-Araf- (1 → indicating the presence → 5) - α -L-Araf- (1 → 2,5) - α -L-Araf- (1 →.
The anomeric hydrogen of α -L-Araf- (1 → correlates with C2 of → 2,5) - α -L-Araf- (1 → indicating the presence of α -L-Araf- (1 → 2,5) - α -L-Araf- (1 →).
→ 2,5) - α -L-Araf- (1 → anomeric H1 and → 3,6) - β -D-Galp- (1 → C3 have related signal peaks; indicating the presence of the → 2,5) - α -L-Araf- (1 → 3,6) - β -D-Galp- (1 → linkage.
In summary, the backbone chain of the polysaccharide of fresh rehmannia glutinosa prepared in example 1 is → 3,6) - β -D-Galp- (1 →, and the side chain is → 5) - α -L-Araf- (1 → 2,5) - α -L-Araf- (1 → arabinose chain, and is connected to the backbone chain via → 3,6) - β -D-Galp- (1 → O-3.
All glycosidic bond signals were assigned according to the information in FIGS. 5-8, and the results are shown in Table 3.
TABLE 3 carbon and hydrogen signal attribution of fresh rehmannia root polysaccharides
Example 3
Pharmacological Activity assay of fresh rehmannia glutinosa polysaccharide prepared in example 1
(1) Apparatus and materials
Carbon dioxide incubator (Thermo corporation, usa); 5920R high speed centrifuge (eppendorf, germany); an Epoch2 microplate reader (BIOTEK, USA); SW-CJ-2F clean bench (Suzhou clean bench Equipment Co., Ltd.).
Mouse mononuclear macrophage RAW264.7 was purchased from shanghai cell bank of chinese academy of sciences; MTT and LPS were purchased from Sigma; penicillin, streptomycin, Fetal Bovine Serum (FBS), DMEM from Gibco; neutral red staining solution was purchased from solibao corporation; mouse Lysozyme (LZM), IL-1 beta, IL-6, TNF-alpha ELISA kits and NO kits were purchased from Wuhan Eleret Biotech GmbH.
The polysaccharide was the fresh rehmannia glutinosa polysaccharide prepared from example 1.
(2) Experimental methods
Influence of fresh rehmannia root polysaccharide on normal RAW264.7 cell biological function
Screening of safe dose: culturing RAW264.7 cells in DMEM medium containing 10% FBS and 1% streptomycin, collecting cells in logarithmic growth phase, and culturing at 4 × 104Cell density per mL was seeded in 96 well cell culture plates, and 200 μ L of cell suspension was added per well. After 24h of culture, the culture solution is sucked out, the FBS-free culture medium is replaced, and a control group and a fresh rehmannia root polysaccharide administration group with series concentration are set: 1, 10, 20, 50, 100. mu.g/mL, 6 duplicate wells, and incubation was continued for 24 h. The MTT method measures the absorbance value of each group of cells at 490nm and calculates the cell survival rate. The results are shown in Table 3.
Neutral red phagocytosis assay: taking cells in logarithmic growth phase at 4X 104The cells are inoculated in 96-well cell culture plates at a cell density of one/mL, and 200. mu.L of cell suspension is added to each well for 24h of culture. The experiments were grouped into blank control, positive control (LPS, 1. mu.g/mL) and concentrationsPolysaccharide administration group, at the concentration of 2.2.1. After 24h of administration and incubation, the stock culture was aspirated, washed with PBS 1 time, 100. mu.L of 0.1% neutral red solution was added to each well, and after 30min, the neutral red solution was completely aspirated and washed with PBS 1 time. Add 200. mu.L of cell lysis buffer (containing 50% ethanol, 1% acetic acid, 49% water) to each well to extract neutral red, and measure the absorbance value of the solution at 540nm with a microplate reader. The results are shown in Table 4.
Effect of fresh rehmannia glutinosa polysaccharide on RAW264.7 cell lysozyme activity, cytokines (IL-1 beta, IL-6, TNF-alpha): taking the concentration of 4 × 104one/mL of the cell suspension in the logarithmic growth phase was inoculated into 24-well plates, 1mL was added to each well, and the cells were cultured in an incubator for 24 hours. Then the experiment is divided into a control group, a positive control group (LPS, 1 mu g/mL) and a fresh rehmannia root polysaccharide group with the concentration of 1, 20, 50 mu g/mL, and the wells are repeated for 4 times, and the treatment is continued for 24 hours. The culture fluid of each group is collected, centrifuged by a centrifuge for 10min (12000r/min) to remove the precipitate, and the determination is carried out according to the mouse lysozyme activity and the kit instructions of the cell factors (IL-1 beta, IL-6 and TNF-alpha). The results are shown in Table 5.
Effect of fresh rehmannia glutinosa polysaccharide on LPS-stimulated RAW264.7 cell biological function: taking the concentration of 4 × 104one/mL of the cell suspension in the logarithmic growth phase was inoculated into 24-well plates, 1mL was added to each well, and the cells were cultured in an incubator for 24 hours. The experiment was divided into a control group, an LPS model group (LPS, 1. mu.g/mL), and 1. mu.g/mLLPS + administration group (1, 20, 50. mu.g/mL) of fresh rehmannia glutinosa polysaccharide at each concentration, and the treatment was continued for 24 hours in 4 wells. The culture fluid of each group is collected, centrifuged by a centrifuge for 10min (12000r/min) to remove the precipitate, and the determination is carried out according to the mouse lysozyme activity and the kit instructions of the cell factors (IL-1 beta, IL-6 and TNF-alpha). The results are shown in Table 6.
TABLE 4 cell proliferation and phagocytic Activity of fresh rehmannia root polysaccharides
Note: p < 0.05, P < 0.01, in contrast to Control group
As can be seen from Table 4, compared with the control group, the cell viability of the polysaccharide group of fresh rehmannia root has no significant change (P is more than 0.05) in the concentration range of 1, 20 and 50 mug/mL, and the cell activity is significantly reduced (P is less than 0.01) at the concentration of 100 mug/mL, which indicates that the high dose has inhibition effect on macrophages; the phagocytosis of neutral red is obviously increased within the concentration range of 1-10 mug/mL (P is less than 0.05 or 0.01), and the phagocytosis capacity is obviously reduced within the concentration range of 50-100 mug/mL (P is less than 0.05), which shows that the fresh rehmannia root polysaccharide has the function of promoting normal macrophages to phagocytize foreign matters within the range of 1-10 mug/mL, and is inhibited within the range of 50-100 mug/mL.
TABLE 5 Effect of fresh rehmannia glutinosa polysaccharide on cytokine and lysozyme secretion from normal macrophages
Note: p < 0.05, P < 0.01, in contrast to Control group
TABLE 6 Effect of fresh rehmannia glutinosa polysaccharide on secretion of cytokines and lysozyme by LPS-stimulated macrophages
Note: in comparison to the set of models,#P＜0.05，##P＜0.01
as can be seen from tables 5 and 6, compared with the control group, the fresh rehmannia root polysaccharide significantly promotes the activity of normal macrophage lysozyme (P is less than 0.01) within the concentration range of 1-50 mug/mL; after LPS stimulation, the content of lysozyme in macrophages is enhanced rapidly, and the lysozyme (P is less than 0.01) can be reduced remarkably by the fresh rehmannia polysaccharide; the fresh rehmannia polysaccharide has no obvious influence on the secretion of TNF-alpha (P is more than 0.05) of normal cells at the concentration of 1 mu g/mL, and obviously promotes normal macrophages to secrete TNF-alpha (P is less than 0.05) at the concentration of 20-50 mu g/mL; the secretion of IL-6 by normal cells is not obviously influenced (P is more than 0.05) when the concentration is 1-20 mu g/mL, and the secretion of normal macrophages and IL-6 are obviously promoted (P is less than 0.01) when the concentration is 50 mu g/mL; the secretion of IL-1 beta by normal macrophages is not obviously influenced (P is more than 0.01) when the concentration is 1-50 mu g/mL; when LPS activates macrophages to secrete cytokines TNF-alpha, IL-6 and IL-1 beta, the fresh rehmannia root polysaccharide inhibits the macrophages to secrete cytokines (P is less than 0.05) within the concentration range of 1-50 mu g/mL. The fresh rehmannia root polysaccharide has a bidirectional immunoregulation effect, improves the phagocytic capacity of macrophages in the early stage of inflammation, promotes the release of lysozyme and cytokines to enhance the immunocompetence of an organism, has certain dose dependence, and improves the excessive release of the lysozyme and the cytokines in inflammatory cells under an inflammatory environment.
The above-described embodiments are merely illustrative of the preferred embodiments of the present invention, and do not limit the scope of the present invention, and various modifications and improvements of the technical solutions of the present invention can be made by those skilled in the art without departing from the spirit of the present invention, and the technical solutions of the present invention are within the scope of the present invention defined by the claims.
Claims (10)
1. The fresh rehmannia root polysaccharide is characterized in that monosaccharide units in the fresh rehmannia root polysaccharide comprise rhamnose, arabinose, galactose and glucose; the molecular weight of the fresh rehmannia root polysaccharide is 17.1 KDa.
2. The fresh rehmannia root polysaccharide of claim 1, wherein the rhamnose: arabinose: galactose: the molar ratio of glucose is 25.1:26.2:28.7: 20.0.
3. a method for preparing the fresh rehmannia glutinosa polysaccharide of claim 1 or 2, comprising the steps of:
(1) carrying out enzymolysis on the fresh rehmannia by using compound enzyme, and precipitating enzymolysis liquid by using alcohol to obtain total polysaccharide of the fresh rehmannia;
(2) removing protein in the total polysaccharide of the fresh rehmannia root obtained in the step (1) by utilizing a Sevag method to obtain a crude polysaccharide solution of the fresh rehmannia root;
(3) separating the crude polysaccharide solution of the fresh rehmannia root obtained in the step (3) by an ion exchange chromatographic column; and performing gel column series chromatography to obtain fresh rehmanniae radix polysaccharide.
4. The preparation method according to claim 3, wherein the compound enzyme in the step (1) is obtained by compounding pectinase and papain in a mass ratio of 1: 1; the mass ratio of the compound enzyme to the fresh rehmannia is 0.15: 100; the volume ratio of the enzymolysis liquid to the fresh rehmannia is (5-10): 1.
5. The preparation method of claim 3, wherein the specific operation of enzymolysis in step (1) is to add complex enzyme, adjust the pH value to 4-5, carry out enzymolysis for 1h at 50 ℃, and then carry out ultrasonic treatment for 1h at 50 ℃ with the ultrasonic power of 80W.
6. The method according to claim 3, wherein the alcohol precipitation in the step (1) is performed to adjust the alcohol concentration of the enzymatic hydrolysate to 90%.
7. The method according to claim 3, wherein the extraction liquid used in the Sevag method in the step (2) is a mixture of chloroform and n-butanol at a volume ratio of 4: 1.
8. The method according to claim 3, wherein the chromatographic conditions for the ion exchange chromatography column separation in step (3) are:
a chromatographic column: DEAE-Sepharose FF column;
flow rate: 50 mL/h;
elution procedure: elution was carried out with water, 0.2M NaCl, 0.5M NaCl, and 2M NaCl in this order.
9. The method according to claim 3, wherein the gel column tandem chromatography conditions in step (3) are:
a chromatographic column: gel Superdex-200;
detection conditions are as follows: LC-10A high performance liquid chromatograph, RI-502 differential detector;
mobile phase: 0.05M NaCl solution, flow rate: 0.6mL/min, column temperature: 40 ℃;
sample introduction amount: 20 μ L.
10. Use of the fresh rehmannia glutinosa polysaccharide of claim 1 or 2 for the preparation of an immunomodulatory or anti-inflammatory drug.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111228586.3A CN113896807A (en) | 2021-10-21 | 2021-10-21 | Fresh rehmannia root polysaccharide and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111228586.3A CN113896807A (en) | 2021-10-21 | 2021-10-21 | Fresh rehmannia root polysaccharide and preparation method and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113896807A true CN113896807A (en) | 2022-01-07 |
Family
ID=79025873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111228586.3A Pending CN113896807A (en) | 2021-10-21 | 2021-10-21 | Fresh rehmannia root polysaccharide and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113896807A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115232225A (en) * | 2022-08-17 | 2022-10-25 | 漳州卫生职业学院 | A kind of Rehmannia glutinosa homogeneous polysaccharide and its preparation method and application |
| CN116355112A (en) * | 2023-03-31 | 2023-06-30 | 吉林农业科技学院 | Low-molecular-weight fritillary polysaccharide, flat fritillary polysaccharide nano-selenium complex, preparation method and application thereof |
| CN116925248A (en) * | 2022-04-08 | 2023-10-24 | 上海中医药大学 | Pollen typhae uniform polysaccharide, preparation method thereof and blood fat reducing application |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109851646A (en) * | 2017-11-30 | 2019-06-07 | 北京国康本草物种生物科学技术研究院有限公司 | A kind of glutinous rehmannia effective component extraction separation method and the Catalpol and polysaccharide of extraction |
-
2021
- 2021-10-21 CN CN202111228586.3A patent/CN113896807A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109851646A (en) * | 2017-11-30 | 2019-06-07 | 北京国康本草物种生物科学技术研究院有限公司 | A kind of glutinous rehmannia effective component extraction separation method and the Catalpol and polysaccharide of extraction |
Non-Patent Citations (1)
| Title |
|---|
| YAN ZHOU等: ""Structural characterization and immunomodulatory activities of two polysaccharides from Rehmanniae Radix Praeparata"", 《INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116925248A (en) * | 2022-04-08 | 2023-10-24 | 上海中医药大学 | Pollen typhae uniform polysaccharide, preparation method thereof and blood fat reducing application |
| CN115232225A (en) * | 2022-08-17 | 2022-10-25 | 漳州卫生职业学院 | A kind of Rehmannia glutinosa homogeneous polysaccharide and its preparation method and application |
| CN115232225B (en) * | 2022-08-17 | 2023-04-14 | 漳州卫生职业学院 | A kind of Rehmannia glutinosa homogeneous polysaccharide and its preparation method and application |
| CN116355112A (en) * | 2023-03-31 | 2023-06-30 | 吉林农业科技学院 | Low-molecular-weight fritillary polysaccharide, flat fritillary polysaccharide nano-selenium complex, preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109400734A (en) | A kind of Polysaccharides from Rosa roxburghii and the preparation method and application thereof | |
| CN113896807A (en) | Fresh rehmannia root polysaccharide and preparation method and application thereof | |
| CN109651532B (en) | Dendrobium officinale glucomannan | |
| CN115746156B (en) | Lycium barbarum polysaccharide with immunomodulatory function and preparation method thereof | |
| CN105294874B (en) | A kind of method for efficiently separating Black Ganoderma immunocompetence polysaccharide | |
| CN107698695A (en) | Homogeneous polysaccharide with immunomodulatory action and preparation method thereof | |
| CN113817076A (en) | Lactobacillus helveticus polysaccharide SGP2-1 with immunoregulatory activity and preparation method and application thereof | |
| CN110845638B (en) | Separation and purification method of rhizoma atractylodis oligosaccharide | |
| CN113274490A (en) | Preparation method and application of botryococcus longipediculus polysaccharide disease-resistant inducer | |
| CN113861303B (en) | Extracellular polysaccharide separated from Lactobacillus delbrueckii and Streptococcus thermophilus fermented yogurt and application thereof | |
| CN112071374B (en) | Mathematical regression model for optimizing cornel leaf polysaccharide extraction and application thereof | |
| CN116655820B (en) | Ampelopsis grossedentata acidic polysaccharide AGP-3a, extraction and separation method thereof and application thereof in preparation of anti-inflammatory cosmetics | |
| CN115232225B (en) | A kind of Rehmannia glutinosa homogeneous polysaccharide and its preparation method and application | |
| CN114790251B (en) | Yunnan rhizoma paridis polysaccharide with immunocompetence and composition and application thereof | |
| CN116731217B (en) | Ampelopsis grossedentata acidic polysaccharide AGP-2a, preparation method thereof and application thereof in preparing anti-inflammatory cosmetics | |
| CN111892662B (en) | Sedum sarmentosum homogeneous polysaccharide and preparation method and application thereof | |
| CN116178580A (en) | Wine-processed Polygonatum sibiricum polysaccharide extract and preparation method thereof | |
| CN114917246A (en) | Application of raspberry polysaccharide R2 in the preparation of antitumor drugs and anti-inflammatory preparations | |
| CN102154404A (en) | Viili extracellular polysaccharide and preparation method thereof | |
| CN105708851A (en) | Horttuyia cordala thunb polysaccharides and derivatives thereof as well as preparation method and pharmaceutical application of horttuyia cordala thunb polysaccharides | |
| CN109206532B (en) | A kind of method for extracting and separating and purifying polysaccharide from myrtle fruit | |
| CN112898445A (en) | Separation and extraction method and application of urtica macrorrhiza polysaccharide | |
| CN113801249B (en) | Preparation method, product and application of rehmannia glutinosa polysaccharide | |
| CN113105567A (en) | Paecilomyces cicadae mannan and preparation and application thereof | |
| CN113244258A (en) | Preparation method and application of spirulina polysaccharide proinflammatory enzyme inducer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |